Maria Teresa Landi | |
---|---|
Alma mater | University of Milan Italian University Consortium |
Scientific career | |
Fields | Cancer epidemiology, genomics, environmental health |
Institutions | National Cancer Institute Johns Hopkins Bloomberg School of Public Health |
Maria Teresa Landi is an Italian epidemiologist and oncologist who researches genetic and environmental determinants of lung cancer and melanoma. At the National Cancer Institute, she is a senior investigator in the integrative tumor epidemiology branch and a senior advisor for genomic epidemiology. Landi is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Landi completed an M.D. summa cum laude from the University of Milan and was trained in oncology and general medicine at the San Raffaele Hospital. [1] She earned a Ph.D. in occupational medicine and industrial hygiene, a subgroup of molecular epidemiology, from an Italian University Consortium in 1993. Landi qualified for the associate professorship in occupational medicine and industrial hygiene in the Italian Universities in 1998. [1]
Landi received tenure in the National Cancer Institute's division of cancer epidemiology and genetics (DCEG) in 2006. [2] She is a senior investigator in the integrative tumor epidemiology branch. [1] She is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. Landi and her team conduct germline and somatic genomic analyses in population studies. [2] In 2021, she was appointed senior advisor for genomic epidemiology in DCEG's trans-divisional research program. [2] Landi's research focuses on understanding tumor etiology and evolution for potential translational applications. She leads large-scale multidisciplinary research projects primarily on genetic and environmental determinants of lung cancer and melanoma. [2] Landi conducts analyses of genomic, transcriptomic, and epigenomic data, and integrates molecular data with histological and radiological imaging and clinical and epidemiological data. [2] She also examines the role of dioxins in cancer risk among highly exposed populations, utilizing markers of exposure and early effect. [2]
Joseph F. Fraumeni Jr. is an American physician and cancer researcher. Born in Boston, he received an A.B. from Harvard College, an M.D. from Duke University, and an M.Sc. in epidemiology from the Harvard School of Public Health. He completed his medical residency at Johns Hopkins Hospital and Memorial Sloan Kettering Cancer Center. He then joined the National Cancer Institute at the National Institutes of Health in 1962 as a commissioned officer of the U.S. Public Health Service, becoming the founding Director of the Division of Cancer Epidemiology and Genetics in 1995. He stepped down from this position in 2012 to become a senior investigator and advisor to the National Cancer Institute.
Gretchen L. Gierach is an American epidemiologist and women's health researcher. She is the chief of the Integrative Tumor Epidemiology Branch in the National Cancer Institute.
Montserrat García-Closas, M.D., M.P.H., Dr.P.H., is a Spanish researcher and academic who is best known for her works on identifying cancer biomarkers and genetic susceptibility to cancer. Dr. García-Closas serves as the deputy director of the Division of Cancer Epidemiology & Genetics (DCEG) of the National Cancer Institute, as well as the Acting Chief of the Integrative Tumor Epidemiology Branch of the DCEG.
Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.
Martha S. Linet is an American physician epidemiologist. She is a scientist emerita at the National Cancer Institute (NCI). Linet retired in January 2020 after 33 years at NCI. She was a senior investigator and branch chief in the NCI radiation epidemiology branch. Linet specialized in epidemiology, the etiology of pediatric and adult leukemia, lymphoma, and brain tumors, as well as the health effects of ionizing and non-ionizing radiation and benzene exposure.
Rachael Zoe Stolzenberg-Solomon is an American epidemiologist and dietitian. She is a senior investigator and head of the metabolic epidemiology branch at the National Cancer Institute.
Laura Elizabeth Beane Freeman is an American environmental epidemiologist who is a senior investigator in the occupational and environmental epidemiology branch at the National Cancer Institute.
Debra Toby Silverman is an American biostatistician and epidemiologist specialized in bladder cancer epidemiology and the carcinogenicity of diesel exhaust. Silverman is the chief of the occupational and environmental epidemiology branch at the National Cancer Institute.
Jill Suzanne Barnholtz-Sloan is an American biostatistician and data scientist specialized in cancer epidemiology and etiologic investigations of brain tumors. She is a senior investigator and associate director for informatics and data science at the National Cancer Institute.
Margaret Anne Tucker is an American oncologist and physician-scientist specialized in environmental and genetic epidemiology, familial cancers, and melanomas. She is a scientist emeritia at the National Cancer Institute (NCI). Tucker was a commissioned officer in the United States Public Health Service Commissioned Corps and served as director of the NCI human genetics program from 2005 until her retirement in June 2018.
Alisa Miriam Goldstein is an American genetic epidemiologist who researches the genetic and environmental causes of cancer. She is a senior investigator at the National Cancer Institute.
Lisa J. Mirabello is an American medical geneticist who researches genetic susceptibility to pediatric cancer and the genomics of HPV carcinogenicity. She is a senior investigator in the clinical genetics branch at the National Cancer Institute.
Aimée Rebecca Kreimer is an American cancer epidemiologist who researches the etiology and prevention of human papillomavirus infection (HPV) and cancer prevention. She is a senior investigator in the infections and immunoepidemiology branch at the National Cancer Institute.
Ludmila Prokunina-Olsson is a molecular medical geneticist who conducts genetic and functional analyses downstream of genome-wide association studies (GWAS) for various human traits, including cancer, immune and infectious diseases. She is chief of the Laboratory of Translational Genomics (LTG) at the National Cancer Institute.
Wen-Yi Huang is a cancer epidemiologist who primarily researches colorectal and prostate tumors. She is a staff scientist in the metabolic epidemiology branch at the National Cancer Institute.
Katherine Ann McGlynn is an American cancer epidemiologist who researches testicular dysgenesis syndrome and hepatocellular carcinoma. She is a senior investigator in the metabolic epidemiology branch of the National Cancer Institute. She was previously a faculty member at the Fox Chase Cancer Center.
Rashmi Sinha is a nutritional and cancer epidemiologist who researches diets, cancer risk, and the microbiome. She is a senior investigator in the metabolic epidemiology branch of the National Cancer Institute.
Sonja Ingrid Berndt is an American pharmacologist and cancer epidemiologist who researches non-Hodgkin lymphoma, prostate cancer, and anthropometric traits that are cancer risk factors. She is a senior investigator in the occupational and environmental epidemiology branch at the National Cancer Institute.
Qing Lan is a Chinese physician-scientist and molecular epidemiologist who researches indoor air pollution, lung cancer, and occupational exposures. She is a senior investigator in the occupational and environmental epidemiology branch at the National Cancer Institute.
Jonine Figueroa is an American epidemiologist specializing in breast cancer epidemiology. She is a senior investigator and distinguished scholar in the integrative tumor epidemiology branch at the National Cancer Institute. She was previously a tenured professor and chair of molecular epidemiology and global cancer prevention at the University of Edinburgh.